Hermetica Superfood Encyclopedia
The Short Answer
Chasmanthera dependens contains quaternary protoberberine alkaloids and tannin-rich stem extracts that exert nephroprotective effects by scavenging reactive oxygen species, restoring glucose-6-phosphate dehydrogenase activity, and suppressing lipid peroxidation markers. In rat models, oral administration of 200–400 mg/kg of tannin-rich stem extract significantly reduced piroxicam-induced elevations in serum creatinine, urea, and albumin compared to controls (p<0.05), though no human clinical trial data currently exists.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordChasmanthera dependens benefits
Star Apple — botanical close-up
Health Benefits
**Nephroprotection**
Tannin-rich stem extracts at 200–400 mg/kg have demonstrated dose-dependent restoration of renal biomarkers (creatinine, urea, albumin, electrolytes) in piroxicam-induced nephrotoxic rat models by reducing ROS generation and restoring antioxidant enzyme activity.
**Antioxidant Activity**
Root chloroform extracts exhibit free radical scavenging properties attributed to phenolics and tannins, reducing lipid peroxidation as measured by decreased malondialdehyde (MDA) levels in preclinical assays.
**Anti-inflammatory Action**
Leaf methanol extracts incorporated into topical gels inhibit key inflammatory mediators including COX-2, TNF-α, IL-10, and PGE-2 in a dose-dependent manner, with activity comparable to the reference drug diclofenac in in vitro assays.
**Analgesic Effect**
Leaf and root extracts prepared in methanol and ethanol have demonstrated pain-relieving properties in traditional use and are supported by in vitro inhibition of prostaglandin synthesis pathways (PGE-2 suppression) relevant to pain signaling.
**Restoration of Antioxidant Enzyme Defense**
Stem extract administration dose-dependently increased glucose-6-phosphate dehydrogenase (G6PD) activity in renal tissue of treated rats, enhancing NADPH production critical for maintaining cellular glutathione levels and oxidative defense.
**Modulation of Hydrolytic Enzymes**
Tannin-rich stem extracts reduced aberrant acetylcholinesterase and ATPase activity in kidneys of piroxicam-treated rats, suggesting a role in protecting cell membrane integrity and neurotransmitter regulation under toxic stress.
**Fever and Malaria Management (Traditional)**
Traditionally used across West Africa for fever reduction and as part of antimalarial plant combinations, though direct antimalarial molecular mechanisms and active plasmodicidal compounds have not yet been isolated or quantified in published studies.
Origin & History
Natural habitat
Chasmanthera dependens is a woody climbing plant native to tropical Africa, distributed across West and Central Africa including Nigeria, Ghana, and Cameroon, where it grows in forest margins, secondary bush, and is commonly planted in home gardens for medicinal purposes. It thrives in humid tropical environments with moderate to high rainfall, typically found at low to mid elevations in forest edge habitats. The plant is documented in Nigerian ethnobotanical records and the PROTA (Plant Resources of Tropical Africa) database as a traditional medicinal climber harvested for its stems, roots, and leaves.
“Chasmanthera dependens has been integrated into West and Central African traditional medicine systems for generations, with documented use in Nigerian, Ghanaian, and Cameroonian ethnomedicine as a remedy for pain, inflammation, and febrile illnesses including malaria. The plant is referenced in the PROTA (Plant Resources of Tropical Africa) database and Nigerian ethnobotanical compilations as a woody climber whose stems, roots, and leaves are harvested for therapeutic decoctions and topical applications. Preparations traditionally involve boiling stem bark or roots to produce aqueous decoctions consumed orally, or crushing fresh leaves for direct topical application to inflamed or painful areas. Its cultivation in home gardens across sub-Saharan Africa reflects its sustained cultural importance as an accessible household remedy, though formal documentation of historical use timelines, ritual significance, or cross-cultural trade remains sparse in the academic literature.”Traditional Medicine
Scientific Research
The published evidence base for Chasmanthera dependens is limited exclusively to preclinical research, comprising animal studies in adult male Wistar rats and in vitro phytochemical and pharmacological assays, with no registered or completed human clinical trials identified in any major database as of current review. The most methodologically detailed study examined tannin-rich stem extract (TRECDS) at 200 and 400 mg/kg orally against piroxicam-induced nephrotoxicity, reporting statistically significant (p<0.05) dose-dependent normalization of serum creatinine, urea, albumin, electrolytes, 5'-nucleotidase, ATPase, and G6PD activity, though exact sample sizes per group were not specified in available summaries. A second line of investigation evaluated formulated topical gels containing leaf methanol extract combined with Chenopodium species, demonstrating COX-2, TNF-α, and PGE-2 inhibition comparable to diclofenac in vitro, with acceptable physicochemical gel parameters (pH, viscosity, spreadability), but without in vivo efficacy or safety confirmation. The overall evidence strength is rated low due to the absence of randomized controlled trials, undefined sample sizes, lack of pharmacokinetic data, and no independent replication of findings across research groups.
Preparation & Dosage
Traditional preparation
**Oral Decoction (Traditional)**
Stem or root bark boiled in water; no standardized preparation volume or concentration established; used empirically across West African communities for fever and pain.
**Oral Extract (Preclinical Animal Dose)**
200–400 mg/kg tannin-rich stem extract (TRECDS) suspended in 2% gum acacia solution administered by gavage in rat studies; human equivalent doses have not been calculated or validated
**Methanol Leaf Extract**
Used in laboratory formulations; no oral dosage for humans defined; extraction typically involves maceration in 70–100% methanol with subsequent evaporation.
**Chloroform Root Extract**
Used in antioxidant assays; preparation involves sequential solvent extraction; no human dose established.
**Topical Gel (Experimental)**
Leaf extract incorporated into 1% carbopol 940 gel base at a Chasmanthera:Chenopodium ratio of 25:75; evaluated for physical parameters only; no clinical dosing regimen established.
**Standardization**
No commercial standardization exists; no marker compound (e.g., specific alkaloid or tannin percentage) has been adopted as a quality benchmark.
**Timing and Duration**
No evidence-based guidance on dosing frequency or treatment duration; traditional use patterns are undocumented in peer-reviewed literature.
Nutritional Profile
No systematic nutritional analysis of Chasmanthera dependens has been published; macronutrient, micronutrient, and caloric composition of any plant part (stem, leaf, root, or fruit) are unquantified in peer-reviewed studies. The fruits are noted as edible in ethnobotanical records but without macronutrient breakdown or vitamin/mineral content data. Phytochemical screening of stem extracts has confirmed the qualitative presence of tannins, quaternary protoberberine alkaloids, non-phenolic quaternary alkaloids, steroids, phenols, and oleic acid; however, no quantitative concentrations (mg/g dry weight or similar) have been published for any compound. Bioavailability of identified phytochemicals is entirely uncharacterized, with no pharmacokinetic studies measuring absorption, distribution, metabolism, or excretion in any species.
How It Works
Mechanism of Action
The nephroprotective action of Chasmanthera dependens stem extract is primarily mediated through antioxidant and enzyme-modulatory pathways: tannins and phenolic compounds scavenge reactive oxygen species (ROS), thereby reducing lipid peroxidation as evidenced by decreased malondialdehyde (MDA) levels, while simultaneously upregulating glucose-6-phosphate dehydrogenase (G6PD) activity to enhance NADPH-dependent regeneration of reduced glutathione. Quaternary protoberberine alkaloids present in stem extracts are hypothesized to contribute to membrane-stabilizing effects, reducing the activity of ATPase and acetylcholinesterase that are dysregulated under NSAID-induced nephrotoxic conditions. In the context of anti-inflammatory activity, leaf extract phytochemicals suppress the arachidonic acid cascade by inhibiting COX-2 enzyme activity and downstream prostaglandin E2 (PGE-2) synthesis, while also downregulating pro-inflammatory cytokines TNF-α and the regulatory cytokine IL-10 in vitro. All identified mechanisms derive from rat and cell-based models; the specific binding affinities, receptor targets, and intracellular signaling cascades in human tissue have not been characterized.
Clinical Evidence
No human clinical trials have been conducted on Chasmanthera dependens for any indication, including its primary traditional uses of fever, malaria, pain, or inflammation. The sole controlled animal study assessed tannin-rich stem extract against piroxicam-induced kidney damage in Wistar rats, measuring biochemical renal markers as primary outcomes; results were statistically significant at doses of 200–400 mg/kg but lacked reported effect sizes such as Cohen's d or confidence intervals, limiting quantitative interpretation. In vitro anti-inflammatory data from topical gel studies showed dose-dependent inhibition of COX-2 and prostaglandins, but these findings have not been validated in living organisms or translated to human pharmacology. Confidence in these results remains very low given the preclinical-only evidence base, absence of toxicological dose-escalation studies, and no peer-reviewed reports of human exposure outcomes.
Safety & Interactions
No human safety data exists for Chasmanthera dependens; available toxicological information is restricted to a rat study in which tannin-rich stem extract at 200–400 mg/kg administered alongside piroxicam produced no observed adverse effects on renal or electrolyte markers, suggesting a preliminary tolerable dose range in rodents only. Tannins as a phytochemical class are known to potentially cause gastrointestinal irritation, constipation, and reduced iron absorption at high doses, and these class-level effects may be relevant to Chasmanthera dependens extracts, though this has not been specifically studied. A notable potential pharmacodynamic interaction exists with NSAIDs such as piroxicam, where stem extract appears to counteract nephrotoxic effects via antioxidant modulation; this could theoretically alter the safety and efficacy profile of concurrent NSAID therapy and warrants clinical caution. Use during pregnancy and lactation is contraindicated by default due to the complete absence of safety data; no maximum safe dose for humans has been established, and individuals with pre-existing renal impairment, liver disease, or those on anticoagulants should avoid use until rigorous human toxicology studies are completed.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Chasmanthera dependensStar Apple (African usage)Tannin-rich climberTRECDS plantNigerian medicinal climber
Frequently Asked Questions
What is Chasmanthera dependens used for in traditional African medicine?
Chasmanthera dependens is used primarily as an analgesic, anti-inflammatory, and fever remedy in West and Central African traditional medicine, with stems, roots, and leaves prepared as decoctions or topical applications. It is also employed in traditional management of febrile illnesses including malaria, though direct antimalarial compounds have not been isolated. Its traditional use is documented in Nigerian ethnobotanical records and the PROTA database.
Is there scientific evidence that Chasmanthera dependens protects the kidneys?
Preclinical evidence from a Wistar rat study shows that tannin-rich stem extract (TRECDS) at 200–400 mg/kg significantly reduced piroxicam-induced elevations in creatinine, urea, albumin, and electrolytes (p<0.05) while restoring glucose-6-phosphate dehydrogenase activity. These findings suggest nephroprotective potential mediated through antioxidant and enzyme-modulatory pathways, but no human clinical trials have confirmed these effects.
What are the active compounds in Chasmanthera dependens?
Stem extracts of Chasmanthera dependens contain quaternary protoberberine alkaloids, non-phenolic quaternary alkaloids, tannins, phenols, steroids, and oleic acid, though specific concentrations have not been quantified in published research. Leaf methanol extracts have tested positive for multiple classes of secondary metabolites, and root chloroform extracts demonstrate antioxidant activity attributed to phenolics and tannins. No single dominant bioactive compound has been isolated and characterized at this time.
What is the recommended dosage of Chasmanthera dependens for humans?
No established human dosage exists for Chasmanthera dependens; all dose data comes from rat studies where 200–400 mg/kg of tannin-rich stem extract was administered orally by gavage. These animal doses cannot be directly translated to human equivalents without allometric scaling studies and human pharmacokinetic data, neither of which have been published. Use outside of traditional empirical practice is not supported by evidence-based dosing guidelines.
Is Chasmanthera dependens safe to use, and are there any drug interactions?
Human safety data for Chasmanthera dependens is entirely absent; rat studies at 200–400 mg/kg showed no observed renal toxicity, but this does not establish human safety parameters. A potential pharmacodynamic interaction with NSAIDs such as piroxicam has been identified in animal models, where the extract counteracts NSAID-induced nephrotoxicity, which could alter therapeutic outcomes if used concurrently. Pregnant or lactating individuals, those with kidney or liver disease, and those on anticoagulant or NSAID therapy should avoid this herb until human safety studies are available.
What is the most effective form of Chasmanthera dependens for kidney protection?
Stem extracts appear to be the most studied and effective form, with research demonstrating nephroprotective effects at 200–400 mg/kg doses in animal models through reduction of reactive oxygen species and restoration of antioxidant enzyme activity. Root chloroform extracts also show antioxidant properties, though stem preparations have more robust evidence for renal biomarker restoration (creatinine, urea, albumin, and electrolyte levels). The tannin content in stem extracts is likely responsible for much of the protective mechanism observed in toxin-induced kidney injury models.
Who should avoid Chasmanthera dependens supplementation?
Individuals with existing kidney disease should consult a healthcare provider before use, as the herb's primary mechanism targets kidney function and interactions with compromised renal systems are not fully characterized. Pregnant and nursing women should avoid this ingredient due to insufficient safety data in these populations. Those taking medications that affect kidney function or antioxidant metabolism should also seek medical guidance before supplementation.
How strong is the current scientific evidence for Chasmanthera dependens' effectiveness?
Current evidence is limited to preclinical animal models, particularly rat studies using piroxicam-induced nephrotoxicity, which show consistent dose-dependent improvements in renal biomarkers and antioxidant enzyme restoration. No published human clinical trials have been conducted to date, meaning efficacy and optimal dosing in people remain unestablished. While the mechanistic data from animal studies is promising, the translation to human supplementation requires controlled clinical research before definitive efficacy claims can be made.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w star-apple-chasmanthera-dependens curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
